Bioimpedance Analyzers Market worth $927 million by 2028
Bioimpedance Analyzers Market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government in promoting healthy lifestyle to curb obesity, growing number of gyms and wellness centers, strong presence of local players in China, and innovation in bioimpedance analyzers technology by integrating with wearable devices.Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144536297&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Multi-frequency bioimpedance analyzers segment is expected to account for the largest share in 2022.
The bioimpedance analyzers market, by product, has been segmented into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to the accurate and precise measurements as compared to single and dual frequency bioimpedance analyzers.
The professional grade bioimpedance analyzers segment held the largest market share in the bioimpedance analyzers market.
By usage type, the global bioimpedance analyzers market is broadly segmented into into consumer-grade and professional-grade bioimpedance analyzers. The professional grade bioimpedance analyzers segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to various factors, such as rising fitness awareness, growing number of obese population, and the growing number of hospitals which is the major end user for professional-grade bioimpedance analyzers.
North America dominates the global bioimpedance analyzers market
Based on the region, the bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America market is driven by rising adoption of bioimpedance analyzers by atheletes to track progress and fitness initiatives by government and local groups. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. The presence of a large population base, strong presence of local players, and increasing rate of obesity are some of the major factors driving the growth of this regional market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=144536297&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Bioimpedance Analyzers Market Dynamics:
Drivers:
Increasing prevalence of lifestyle diseases
Initiatives by governments and private organizations to promote healthy lifestyles
Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
Restraints:
Presence of alternative methods
High cost of analyzers
Opportunities:
Emerging markets across Asia Pacific and Latin America
Integration with wearable devices
Challenges:
Inconsistency in accuracy of different bioimpedance analyzers
Key Market Players:
Major players in bioimpedance analyzers market include OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), and seca GmbH & Co. KG (Germany).
Recent Developments:
In 2023, Bodystat Ltd. (UK) launched the Multiscan 5000, which incorporates the latest state-of-the-art bioelectrical impedance spectroscopy (BIS) technology based on direct digital synthesis, digital signal processing, and active shielding technology.
In 2023, InBody Co., Ltd. (South Korea) announced it would supply the US Marine Corps with body composition analysis devices. The US Marine Corps announced refinements in its body composition assessment methods using the InBody 770 analyzer.
In 2022, InBody Co., Ltd. (South Korea) partnered with iLoveKickboxing (US). The partnership offered iLoveKickboxing members access to high-quality data about their body fat percentage, muscle mass, and other biometrics. It enabled them to monitor changes over time via the InBody App.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=144536297&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioimpedance Analyzers Market worth $927 million by 2028 here
News-ID: 3314648 • Views: …
More Releases from marketsandmarket
With 13.6%CAGR, Zinc Battery Market Growth to Surpass USD 2.0 billion
According to MarketsandMarkets, the Zinc Battery Market is estimated to be USD 1.0 billion in 2024 and projected to reach USD 2.0 billion by 2029, at a CAGR of 13.6% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171978019
Zinc batteries are anticipated to play a critical role in the future energy landscape, driven by the global shift from fossil fuels to renewable energy sources. This transition necessitates substantial electricity storage…
Strategic Innovations in Industrial Valves Industry Leading to $99.8 Billion Mar …
The global industrial valves market size is expected to grow from USD 80.4 billion in 2023 to USD 99.8 billion by 2028, at a CAGR of 4.4%. The growth of the industrial valves market can be attributed to the growing demand for industrial valves from healthcare and pharmaceutical industries, establishment of new power plants and revamping of existing ones, rising demand for adoption of automation solutions, and establishment of smart…
Vaccines Market worth $93.8 billion by 2028
Vaccines Market in terms of revenue was estimated to be worth $77.6 billion in 2023 and is poised to reach $93.8 billion by 2028, growing at a CAGR of 3.9% from 2023 to 2028 according to a new report by MarketsandMarkets.
The global vaccines market is expected to grow at a CAGR of 3.9% during the forecast period. The growth of the market is projected to be driven by factors such…
Global Livestock Monitoring Market Share To worth USD 3.7 billion by 2030 | CAGR …
The global livestock monitoring market in terms of revenue was estimated to be worth USD 1.6 billion in 2022 and is poised to reach USD 3.7 billion by 2030, growing at a CAGR of 11.0% from 2022 to 2030. The new research study consists of an industry trend analysis of the market.
The report profiles key players such as Allflex Livestock Intelligence (Subsidiary of MSD Animal Health) (US), DeLaval (Sweden), Afimilk…
More Releases for Bioimpedance
Bioimpedance Analyzers Market Revenue, Region & Country Share, Trends, Growth An …
The global Bioimpedance Analyzers market size is expected to reach USD 1,019.20 million by 2030 according to a new study by Polaris Market Research.
The report "Bioimpedance Analyzers Market Share, Size, Trends, Industry Analysis Report, By Product (Multiple-frequency, Single-frequency, and Dual-frequency), By Modality, By Application, By End Use, By Region; Segment Forecast, 2022-2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Request Sample Copy…
Bioimpedance Devices Market Size, Share, Growth, Trends, Analysis and Forecast - …
Increasing cases of CKD disease are expected to aid the growth of the global bioimpedance device market. Chronic kidney disease (CKD) is a medical disorder in which kidney function is lost over time. Bioimpedance devices help to predict muscle mass and improve glomerular function in these patients.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Bioimpedance Devices Market at: https://www.orionmarketreports.com/bioimpedance-devices-market/48701/#ert_pane1-1
Key Players:
The major players that are operating in the global…
Single-frequency Bioimpedance Devicess Market: Competitive Dynamics & Global Out …
New report published by Market Research Report Store (MRRS) which offers insights on the global Single-frequency Bioimpedance Devicess market.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/242079/global-single-frequency-bioimpedance-devicess-market
Global Single-frequency Bioimpedance Devicess Market: Forecast by Type / Application / Region
According to this study, over the next five years the Single-frequency Bioimpedance Devicess market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million…
Bioimpedance Devices Market to Garner at a 6.5% CGR by 2028
Multiple-Frequency Bioimpedance Devices to Witness Increasing Adoption Through 2028
Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance devices market throughout the forecast period. Chronic kidney disease (CKD) is a medical condition that can be characterized by gradual loss of kidney function over time. As per the National Kidney Foundation, Inc., 30 million American adults have Chronic Kidney Disease and millions of others are at…
Bioimpedance Device Market Market Promising Growth Opportunities over 2017 to 20 …
The bioimpedance devices have a huge potential in different healthcare applications. Moreover, the development of wearable devices which can perform the bioimpedance measurements is expected to further propel the market for the bioimpedance market. The evolution of bioimpedance spectroscopy has also helped to study the electric properties of materials. The knowledge and know-how of the biological cells and tissues comes from the bioimpedance technology.
Bioimpedance Device Market: Drivers and Restraints
A balanced…
Bioimpedance Device Market Registering a Strong Growth by 2027
The bioimpedance devices have a huge potential in different healthcare applications. Moreover, the development of wearable devices which can perform the bioimpedance measurements is expected to further propel the market for the bioimpedance market. The evolution of bioimpedance spectroscopy has also helped to study the electric properties of materials. The knowledge and know-how of the biological cells and tissues comes from the bioimpedance technology.
Bioimpedance Device Market: Drivers and Restraints
A balanced…